BlackRock, Inc. 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-10 12:54 pm Sale |
2021-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
BlackRock Inc. BLK |
125,391 4.800% |
-1,029 (-0.81%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
BlackRock Inc. BLK |
126,420 5.600% |
126,420 (New Position) |
Filing |